Peter Guenter
Direktor/Vorstandsmitglied bei GALAPAGOS NV
Vermögen: 56 614 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Peter Guenter
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
47
| Public Company | Pharmaceuticals: Major | 47 |
30
| Public Company | Biotechnology | 30 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.
26
| Non-Profit Organization | Miscellaneous Commercial Services | 26 |
| Public Company | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter Guenter
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Operating Officer Sales & Marketing Chief Executive Officer President Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer | |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | Food: Specialty/Candy | Chief Executive Officer Chief Executive Officer Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| SANOFI | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Chairman Director/Board Member | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal President Corporate Officer/Principal Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact Investor Relations Contact | |
| SAP SE | Packaged Software | Corporate Officer/Principal Director/Board Member | |
| UCB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Corporate Officer/Principal | |
Zentiva Group as
 Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree | |
| Technische Universität München | College/University | Doctorate Degree Corporate Officer/Principal | |
| Technische Universität Darmstadt | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal President President | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chairman Chairman Corporate Officer/Principal Director/Board Member | |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Leem | Founder Director/Board Member | ||
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| PHARNEXT SCA | Biotechnology | Director/Board Member Chairman | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member President | |
Zentiva NV
 Zentiva NV Pharmaceuticals: GenericHealth Technology Zentiva NV manufactures and markets branded generic pharmaceutical products. The company is headquartered in Amsterdam, the Netherlands. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Verband Forschender Arzneimittelhersteller eV
 Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Industriegewerkschaft Bergbau Chemie Energie
 Industriegewerkschaft Bergbau Chemie Energie Miscellaneous Commercial ServicesCommercial Services Industriegewerkschaft Bergbau Chemie Energie operates as a trade union. The private company is based in Hannover, Germany. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member | |
Verband der Chemischen Industrie eV
 Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| Hochschule für Wirtschaft und Recht Berlin | College/University | Undergraduate Degree Undergraduate Degree | |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Drugstore Chains | Chairman Director/Board Member | |
| DUPONT DE NEMOURS, INC. | Chemicals: Major Diversified | Director/Board Member Corporate Officer/Principal | |
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Aicuris Anti-Infective Cures AG
 Aicuris Anti-Infective Cures AG Miscellaneous Commercial ServicesCommercial Services Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chairman Founder | |
| Merck Healthcare KGaA | Corporate Officer/Principal Chairman Director/Board Member | ||
| Merck Healthcare | Chief Operating Officer Chief Executive Officer | ||
| Merck Life Science KGaA | Director/Board Member Chairman Director/Board Member | ||
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal |
Statistik
International
| Deutschland | 17 |
| Vereinigte Staaten | 14 |
| Frankreich | 6 |
| Schweiz | 6 |
| Dänemark | 4 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 10 |
| Commercial Services | 8 |
| Consumer Non-Durables | 2 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 477 |
| Corporate Officer/Principal | 248 |
| Chief Executive Officer | 175 |
| Chairman | 110 |
| Independent Dir/Board Member | 106 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Helene von Roeder | 84 |
| Raj Bhikhu Parekh | 50 |
| Enrique de Leyva Pérez | 44 |
| Marie-Laure Jeanne Antoinette Pochon | 36 |
| Dieter Weinand | 32 |
| Joseph Jimenez | 32 |
| Marc M. P. de Garidel | 31 |
| Ian Read | 29 |
| Wolfgang Heinz Büchele | 28 |
| Ulf Arne Wiinberg | 26 |
| Peter Andersen | 26 |
| Stefan Oschmann | 23 |
| Jérôme Contamine | 23 |
| Belén Garijo López | 22 |
| Andreas Fibig | 21 |
- Börse
- Insiders
- Peter Guenter
- Unternehmensverbindungen
